(PharmaNewsWire.Com, March 12, 2018 ) The global collagen market for regenerative medicine is projected to grow from USD 420.6 Million in 2017 to USD 679.9 Million by 2022, at a CAGR of 10.1% during the forecast period. The global gelatin market for regenerative medicine is projected to grow from USD 65.2 Million in 2017 to USD 94.9 Million by 2022, at a CAGR of 7.8% during the forecast period. The key factors propelling the growth of the global collagen and gelatin market for regenerative medicine include rising prevalence of chronic diseases, rapid growth in aging population, and growing government & private funding to support the development of regenerative medicine.
The report analyzes the global collagen & gelatin market for regenerative medicine by source, application, and region. On the basis of source, the global collagen market for regenerative medicine has been segmented into bovine collagen, porcine collagen, marine collagen, and other sources. In 2017, the bovine collagen segment is expected to command the largest share of the global collagen market for regenerative medicine. The large share of this segment is attributed to the lower cost and extensive availability of bovine collagen. Similarly, on the basis of source, the global gelatin market for regenerative medicine has been segmented into bovine gelatin, porcine gelatin, and gelatin from other sources. In 2017, the bovine gelatin segment is expected to command the largest share of the global gelatin market for regenerative medicine. Owing to its extensive availability, this segment is also projected to register the highest CAGR during the forecast period.
On the basis of application, the global collagen market for regenerative medicine has been categorized into orthopedic, wound care, cardiovascular, and other applications. The orthopedic applications segment is expected to command the largest share of the global collagen market for regenerative medicine in 2017. The large share of this segment can primarily be attributed to the high prevalence of osteoporosis. The wound care segment is projected to register the highest CAGR during the forecast owing to factors such as rising prevalence of chronic wounds.
The global gelatin market for regenerative medicine, by application, has been categorized into wound care, orthopedic, cardiovascular & thoracic, and other applications. The wound care segment is expected to command the largest share of the global gelatin market for regenerative medicine in 2017. The large share of this segment can be attributed to its advantages such as being comfortable to the patient due to their cooling effect and non-adhesiveness to wound tissue.
Geographically, the global collagen & gelatin market for regenerative medicine is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, North America dominated the market, and this is primarily attributed to high incidence of periodontitis, increasing prevalence of heart diseases & diabetes in the U.S., and growing number of research studies in Canada. The Asia-Pacific region is expected to witness the highest CAGR during the forecast period, owing to the large number of CVD patients and diabetics with DFU (diabetic foot ulcers) in the region, increasing number of research studies, and increasing focus of industry players on emerging APAC countries.
The major players operating in the global gelatin market for regenerative medicine include GELITA AG (Germany), Nitta Gelatin, Inc. (Japan), and PB Gelatin (Belgium). Similarly, the major players operating in the global collagen market for regenerative medicine include Royal DSM (Netherlands), Integra LifeSciences Holding Corporation (U.S.), Collagen Solutions plc (U.K.), Vornia Biomaterials, Ltd. (Ireland), Collagen Matrix, Inc. (U.S.), SYMATESE (France), and NuCollagen, LLC. (U.S.).
About Us: Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
